CiteFacts · FDA Drug Shortages · FDA source
Cromolyn Sodium Concentrate
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96) | Limited Availability | 07/17/2026 |
| Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96) | Limited Availability | 07/17/2026 |
| Ailex Pharmaceuticals | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96) | Available | 07/17/2026 |
| Micro Labs LTD | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52) | Available | 08/17/2026 |
| Mylan Specialty, a Viatris Company | Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96) | Available | 08/20/2026 |
| Rising Pharma Holdings, Inc. | Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 16571-600-96) | Available | 07/01/2026 |
Source facts
Grouped generic ingredient: Cromolyn Sodium Concentrate · 6 package records · Latest FDA row update: 08/20/2026
Therapeutic categories: Pulmonary/Allergy
Dosage forms: Concentrate
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.